Serving the Animal Health Market

Seamless development and manufacturing for biopharmaceutical products

MORE ABOUT US

A newly established, end-to-end CDMO service provider

Vioti is a newly established, end-to-end CDMO service provider aimed at offering seamless development and manufacturing for biopharmaceutical products.

Vioti is fully dedicated to Animal Health. 

Our focus is the end-to-end development and manufacturing of biologic Drug Substance and Drug Product. 

Vioti’s technological capabilities include Upstream/Downstream of mammalian and microbial fermentation, compounding, aseptic filling in vials and final packaging. 

The site is designed to be EU GMP / Annex 1 fully compliant. 

The site will comply to EU GMP, US FDA and USDA. Additional registrations will follow customers needs. 

About Us

Plant compliant with global GMP, EU and US regulations, combining energy-efficient building (low primary energy demands), and utilities & equipment with minimum carbon footprint, utilizing renewable energy sources.

2023

Concept Design

2024

Construction Kick Off

2025

Construction Completion

2026

Plant Fully Operating

Capabilities

Biological Drug Development

Equipped to support the development of biological Drug Substances and Products, such as antigens for vaccines and monoclonal antibodies

Scale up & Technology Transfer

Provide equipment and support services for the transfer of processes from client’s R&D into pilot and manufacturing scale

Upstream & Downstream Processing

Designed to produce in large scale drug substances originating both from mammalian and microbial cell cultures

Compounding

Accommodate best the compounding of both biologics and small molecule ingredients

Aseptic Filling

Sterile liquid filling of parenteral solutions in vials (plastic & glass, both ready-to-use and vials to be sterilized), combination of filling lines with disposable technologies and stainless steel alternative.
EU GMP Annex 1 compliant

Packaging

Visual inspection, and secondary and final packaging including most recent traceability requirements

ESG

The most recent environmental standards are taken into account to establish a sustainable veterinary drug CDMO plant: electric energy needs covered by renewable sources and a low CO2 footprint.

MORE ABOUT ESG